Pembrolizumab for neoadjuvant and adjuvant treatment of resectable locally advanced head and neck squamous cell carcinoma (TA1145)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 21 April 2026
Nivolumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy (TA736)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 20 October 2021
Pembrolizumab for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma (TA661)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 November 2020
Pembrolizumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy (terminated appraisal) (TA570)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 20 March 2019
Dinutuximab beta for treating neuroblastoma (TA538)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 22 August 2018
Cancer of the upper aerodigestive tract: assessment and management in people aged 16 or over (NG36)Product type:GuidanceProgramme:NICE guidelineLast updated: 6 June 2018Published: 10 February 2016
Cetuximab for treating recurrent or metastatic squamous cell cancer of the head and neck (TA473)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 31 August 2017
Minimally invasive video‑assisted parathyroidectomy (HTG350)Product type:GuidanceProgramme:HealthTech guidancePublished: 23 August 2014
Minimally invasive video-assisted thyroidectomy (HTG349)Product type:GuidanceProgramme:HealthTech guidancePublished: 23 August 2014
Transoral carbon dioxide laser surgery for primary treatment of oropharyngeal malignancy (HTG337)Product type:GuidanceProgramme:HealthTech guidancePublished: 27 March 2014
Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck (TA145)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 June 2008
Interstitial photodynamic therapy for malignant parotid tumours (HTG166)Product type:GuidanceProgramme:HealthTech guidancePublished: 23 April 2008
Thoracoscopic excision of mediastinal parathyroid tumours (HTG159)Product type:GuidanceProgramme:HealthTech guidancePublished: 12 December 2007
Improving outcomes in head and neck cancers (CSG6)Product type:GuidanceProgramme:Cancer service guidelinePublished: 24 November 2004
Endoscopic transsphenoidal pituitary adenoma resection (HTG14)Product type:GuidanceProgramme:HealthTech guidancePublished: 17 December 2003